• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

亨廷顿舞蹈症中烟酰胺腺嘌呤二核苷酸（NADH）：泛醌氧化还原酶（复合体I）存在缺陷的证据。

Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease.

作者信息

Parker W D, Boyson S J, Luder A S, Parks J K

机构信息

Department of Neurology, University of Colorado School of Medicine, Denver.

出版信息

Neurology. 1990 Aug;40(8):1231-4. doi: 10.1212/wnl.40.8.1231.

DOI:10.1212/wnl.40.8.1231
PMID:2143271
Abstract

We evaluated electron transport chain activity in platelet mitochondria taken from HD patients. All 5 patients studied had striking depressions of NADH:ubiquinone oxidoreductase activity (complex I) (5.36 +/- 2.91 nmol/min/mg; control mean, 19.12 +/- 5.64 nmol/min/mg). Other electron transport chain activities were not significantly different from control values. HD may be caused by a mutation in 1 of the nuclear coded subunits of NADH:ubiquinone oxidoreductase.

摘要

我们评估了来自HD患者的血小板线粒体中的电子传递链活性。所有5名接受研究的患者的NADH：泛醌氧化还原酶活性（复合体I）均显著降低（5.36±2.91 nmol/分钟/毫克；对照组平均值为19.12±5.64 nmol/分钟/毫克）。其他电子传递链活性与对照值无显著差异。HD可能是由NADH：泛醌氧化还原酶的一个核编码亚基发生突变引起的。

相似文献

1
Evidence for a defect in NADH: ubiquinone oxidoreductase (complex I) in Huntington's disease.亨廷顿舞蹈症中烟酰胺腺嘌呤二核苷酸（NADH）：泛醌氧化还原酶（复合体I）存在缺陷的证据。
Neurology. 1990 Aug;40(8):1231-4. doi: 10.1212/wnl.40.8.1231.
2
A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy.
N Engl J Med. 1989 May 18;320(20):1331-3. doi: 10.1056/NEJM198905183202007.
3
Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases.线粒体疾病中NADH-泛醌氧化还原酶（复合体I）的分子缺陷
J Bioenerg Biomembr. 1988 Jun;20(3):365-82. doi: 10.1007/BF00769638.
4
Abnormalities of the electron transport chain in idiopathic Parkinson's disease.特发性帕金森病中电子传递链的异常
Ann Neurol. 1989 Dec;26(6):719-23. doi: 10.1002/ana.410260606.
5
A small isoform of NADH:ubiquinone oxidoreductase (complex I) without mitochondrially encoded subunits is made in chloramphenicol-treated Neurospora crassa.在氯霉素处理的粗糙脉孢菌中产生了一种不含线粒体编码亚基的NADH：泛醌氧化还原酶（复合体I）的小异构体。
Eur J Biochem. 1989 Mar 1;180(1):173-80. doi: 10.1111/j.1432-1033.1989.tb14629.x.
6
Extensive defects of mitochondrial electron-transfer chain in muscular cytochrome c oxidase deficiency.肌肉细胞色素c氧化酶缺乏症中线粒体电子传递链的广泛缺陷。
Pediatr Res. 1988 Oct;24(4):447-54. doi: 10.1203/00006450-198810000-00006.
7
Deficiency of the iron-sulfur clusters of mitochondrial reduced nicotinamide-adenine dinucleotide-ubiquinone oxidoreductase (complex I) in an infant with congenital lactic acidosis.一名先天性乳酸性酸中毒婴儿线粒体还原型烟酰胺腺嘌呤二核苷酸 - 泛醌氧化还原酶（复合体I）铁硫簇缺乏。
J Clin Invest. 1984 Sep;74(3):685-97. doi: 10.1172/JCI111484.
8
Human mitochondrial respiratory chain deficiencies.人类线粒体呼吸链缺陷
Aust Paediatr J. 1988;24 Suppl 1:55-7.
9
[NADH-CoQ reductase deficiency].[烟酰胺腺嘌呤二核苷酸（NADH）-辅酶Q还原酶缺乏症]
Tanpakushitsu Kakusan Koso. 1988 Apr;33(5):828-30.
10
Normal platelet mitochondrial complex I activity in Huntington's disease.亨廷顿舞蹈症患者血小板线粒体复合物I活性正常。
Neurobiol Dis. 2007 Jul;27(1):99-101. doi: 10.1016/j.nbd.2007.04.008. Epub 2007 May 5.

引用本文的文献

1
Leveraging explainable deep learning methodologies to elucidate the biological underpinnings of Huntington's disease using single-cell RNA sequencing data.利用可解释的深度学习方法，利用单细胞 RNA 测序数据阐明亨廷顿病的生物学基础。
BMC Genomics. 2024 Oct 4;25(1):930. doi: 10.1186/s12864-024-10855-5.
2
Dysregulation of PGC-1α-Dependent Transcriptional Programs in Neurological and Developmental Disorders: Therapeutic Challenges and Opportunities.神经发育障碍中 PGC-1α 依赖性转录程序失调：治疗挑战与机遇。
Cells. 2021 Feb 9;10(2):352. doi: 10.3390/cells10020352.
3
iTRAQ-Based Proteomic Analysis of Dentate Gyrus in Temporal Lobe Epilepsy With Hippocampal Sclerosis.
基于iTRAQ的海马硬化型颞叶癫痫患者齿状回蛋白质组学分析
Front Neurol. 2021 Jan 25;11:626013. doi: 10.3389/fneur.2020.626013. eCollection 2020.
4
Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models.线粒体功能衰竭与氧化应激在神经退行性变中的作用及其计算模型
Antioxidants (Basel). 2021 Feb 3;10(2):229. doi: 10.3390/antiox10020229.
5
Blood-based bioenergetics: An emerging translational and clinical tool.基于血液的生物能量学：一种新兴的转化和临床工具。
Mol Aspects Med. 2020 Feb;71:100835. doi: 10.1016/j.mam.2019.100835. Epub 2019 Dec 18.
6
Axonal Transport and Mitochondrial Function in Neurons.神经元中的轴突运输与线粒体功能
Front Cell Neurosci. 2019 Aug 9;13:373. doi: 10.3389/fncel.2019.00373. eCollection 2019.
7
Mitochondrial Respiratory Function in Peripheral Blood Cells from Huntington's Disease Patients.亨廷顿舞蹈症患者外周血细胞中的线粒体呼吸功能
Mov Disord Clin Pract. 2016 Feb 11;3(5):472-482. doi: 10.1002/mdc3.12308. eCollection 2016 Sep-Oct.
8
Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients.亨廷顿病患者皮肤成纤维细胞中线粒体改变伴氧化应激状态。
Metab Brain Dis. 2018 Dec;33(6):2005-2017. doi: 10.1007/s11011-018-0308-1. Epub 2018 Aug 17.
9
Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.胰岛素及胰岛素增敏药物在神经退行性变中的作用：线粒体作为治疗靶点
Pharmaceuticals (Basel). 2009 Dec 23;2(3):250-286. doi: 10.3390/ph2030250.
10
Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.氧化应激与亨廷顿舞蹈症：益处、危害与严峻之处
J Huntingtons Dis. 2016 Oct 1;5(3):217-237. doi: 10.3233/JHD-160205.